根据两项新的重大研究结果,一种治疗某种特定类型乳腺癌的药物即将使医生对乳腺癌的治疗方法产生重大改变。这两项研究结果显示,赫赛汀能使HER2阳性的女性乳腺癌患者的复发率风险减半。HER2阳性肿瘤能产生更多的 HER2蛋白,该蛋白又与更多侵润性乳腺癌有关并使乳腺癌的死亡风险增高。赫赛汀是一种能用来抑制 HER2蛋白活性的药物。在新近的《新英格兰医学杂志》上,得州大学安德 According to the results of two new major studies, a drug that treats a particular type of breast cancer is about to make a major change in how doctors treat breast cancer. The results of these two studies show that Herceptin can halve the risk of recurrence of HER2-positive breast cancer in women. HER2-positive tumors produce more HER2 protein, which is associated with more invasive breast cancer and increases the risk of breast cancer death. Herceptin is a drug that can be used to inhibit the activity of HER2 protein. In the recent New England Journal of Medicine, University of Texas